Dr. Iulia Giuroiu, MD

Dr. Giuroiu practices at El Camino Health - Mountain View Hospital in Mountain View, California, part of El Camino Healthcare District.

Dr. Giuroiu's NPI, 1417247842, was assigned on April 19, 2011. Dr. Giuroiu graduated from David Geffen School of Medicine at UCLA in 2011. Dr. Giuroiu holds California license A155292.

Dr. Giuroiu's primary practice is El Camino Health - Mountain View Hospital, at 2500 Grant Road, Mountain View, CA 94040 in Santa Clara County. The practice phone is (650) 940-7000.

Dr. Giuroiu's primary practice is El Camino Health - Mountain View Hospital in Mountain View, California, part of El Camino Healthcare District. Dr. Giuroiu is also affiliated with Stanford Hospital at 300 Pasteur Drive. The medical group on file is Palo Alto Foundation Medical Group. Dmand AI also links Dr. Giuroiu to 1 more hospital, 2 hospital outpatient departments and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Giuroiu practices, 5 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Giuroiu's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Giuroiu is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Giuroiu's licenses on file in 2 states: California and New York.

Dmand AI lists breast cancer, chronic anemia, colorectal cancer, deep vein thrombosis (DVT), fluid and electrolyte imbalances, lung cancer, multiple myeloma and prostate cancer among the conditions Dr. Giuroiu treats.

CMS data shows 384 Medicare services from Dr. Giuroiu across 7 procedure codes in 2024, for 228 Medicare patients. Medicare paid $29,296 for them.

CMS counts 228 Medicare patients who saw Dr. Giuroiu in 2024. The largest group is 75 to 84, with 87 patients. 72% of them have high blood pressure, and 63% have high cholesterol. 30% are also on Medicaid. Their average risk score is 1.90, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Giuroiu's median patient age at 71, with 63% women.

In 2024, Dr. Giuroiu wrote 462 Medicare Part D claims for 91 patients. 85% of them were for generic drugs. CMS names the drug for 275 of them, across 10 drugs with 11 or more claims each, at $84,554 in total drug cost. In 2023, CMS named 364 claims across 14 drugs.

Dr. Giuroiu accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Giuroiu as offering telehealth.

Dmand AI links 4 papers to Dr. Giuroiu in 2020. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols. Dr. Giuroiu's most frequent co-author is Diane L. Reidy-Lagunes, MD, MS.

CMS Open Payments shows 20 general payments to Dr. Giuroiu from 9 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 71% of the total. Genentech, Inc. paid the most, $263.

Dr. Giuroiu graduated from David Geffen School of Medicine at UCLA in 2011.

Dr. Giuroiu is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.